About PacBio
PacBio is a publicly listed company based in Menlo Park (United States) founded in 2004. Instrument systems and software for single-molecule real-time sequencing are developed. It operates in the Healthcare and Technology sectors. PacBio has raised $395 million across 11 funding rounds from investors including Morgan Stanley, Kleiner Perkins and SoftBank Group. The company has 575 employees. PacBio has completed 2 acquisitions, including Circulomics and Omniome. Its chief executive, as recorded, is Christian Henry. Its website pacb.com draws about 116 thousand monthly visits. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Instruments and Genomics. Its legal entity is PACIFIC BIOSCIENCES OF CALIFORNIA, INC. Its competitors include Omniome, Complete Genomics and Bionano; 3 of its 3 listed competitors have raised funding.
Company details
PacBio was founded in 2004 in Menlo Park, United States, within the biotechnology sector. Instrument systems and associated software for real-time sequencing of single molecules are developed by the company. A sequencing platform based on two proprietary technologies is utilized to enable this process. Analytical software for refining sequence data processing and generating reports is also provided, supporting operations in genomic research across the United States.
- Annual Revenue$160 M (USD)3.89as on Dec 31, 2025
- Net Profit-$546.38 M (USD)-76.34as on Dec 31, 2025
- EBITDA-$165.3 M (USD)22.07as on Dec 31, 2025
- Total Equity Funding$395M (USD)
in 11 rounds
- Latest Funding Round$900M (USD), Post-IPO
Feb 2021
- InvestorsMorgan Stanley
& 20 more
- Employee Count575
- Investments & AcquisitionsCirculomics
& 1 more
Apps and channels of PacBio
its YouTube channel PacBio has 6.11K subscribers and 30 videos.
Videos from PacBio
The most watched videos on PacBio's YouTube channel, PacBio (6.11K subscribers). Click a video to play it here.
More on PacBio.
Funding Insights of PacBio
PacBio has successfully raised a total of $395M across 11 strategic funding rounds. The most recent funding activity was a Post-IPO round of $900 million completed in February 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $395M
- Total Rounds 11
- Last Round Post-IPO — $900M
- First Round $50M
(Jan 2007)
- Investors Count 21
Latest 10 of 11 funding rounds of PacBio with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Feb 2021 | $900M | Post-IPO | – | – | |
| Feb 2013 | $20.5M | Debt – Conventional | – | – | – |
| Jul 2010 | $109M | Series F | – | Deerfield Triarc Capital, DAG Ventures | |
| Jun 2010 | $1.97M | Grant | – | – | |
| Jun 2010 | $1.97M | Grant | – | – | |
| Oct 2009 | $68M | Series E | – | – | – |
| Sep 2009 | $4.07M | Grant | – | – | |
| Aug 2009 | $68M | Series E | – | Sutter Hill Ventures, Byers Engineering | |
| Jul 2008 | $100M | Series E | – | Deerfield, Intel Capital | |
| Jun 2007 | $2.88M | Grant | – | – |
21 investors in total: 21 institutional.
Investors in PacBio
PacBio has secured backing from 21 investors, including institutional and venture fund investors. Prominent investors backing the company include Morgan Stanley, Kleiner Perkins and SoftBank Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are managed in technology and healthcare sectors by this firm. | mdv.com | |||
Mid-stage venture capital investments and support for tech entrepreneurs. | dagventures.com | |||
Early stage venture capital firm investing in the US | alloyventures.com | Palo Alto, United States | ||
Private debt fund focused on multiple sectors | 1967 | alliancebernstein.com | New York, United States | |
VC firm investing in the US | shv.com | Palo Alto, United States | ||
Venture capital firm investing in early-stage tech startups | 1972 | kleinerperkins.com | Menlo Park, United States | |
Early-stage tech and life-sciences firms are funded across the US. | maverickventures.com | San Francisco, United States | ||
Healthcare ecosystem is supported through investment and innovation by Deerfield. | deerfield.com | New York, United States | ||
Investment in technology startups focusing on compute, AI, and related innovations. | intelcapital.com | |||
Diversified investment management is provided across multiple asset classes. | 1985 | blackstone.com | New York, United States |
Investor details for PacBio
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of PacBio
59 people are tracked at PacBio (26 in leadership, 8 in board & advisors, 25 in team); the tracked headcount is 575.
| Name | Role | Group |
|---|---|---|
Christian Henry | CEO & President | Leadership |
Mark Van Oene | COO | Leadership |
Natalie Welch | Chief People Officer | Leadership |
Michele Farmer | Chief Accounting Officer | Leadership |
Marybeth Blood | Director, Content And Marketing Programs | Leadership |
Mathieu Foquet | Director | Leadership |
Elizabeth Tseng | Associate Director, Product Marketing, Applications | Leadership |
Jim Gibson | Chief Financial Officer | Leadership |
Caleb McCanne | Associate Director, Global Commercial Operations | Leadership |
Nicole M Ellis-Ovadia | Associate Director Segment Marketing, Human Genomics : Neurogenomics, Population Genomics | Leadership |
Shawna Owen | Associate Director, Global Commercial Support | Leadership |
Peter Perino | Director Distribution, Logistics, & Facilities | Leadership |
Nicole Jeleniowski | Director Of Finance | Leadership |
Alvin Hom | Head Of Global Talent Acquisition | Leadership |
Trang Dahlen | Senior Director, Segment Marketing, Global | Leadership |
Will Morrison | Vp, Global Legal | Leadership |
Michael Paumen | Head Of Japan | Leadership |
Amit Patel | Senior Director Product Marketing | Leadership |
Amber Stull | Director, Accounting | Leadership |
David Miller | Vice President Global Marketing | Leadership |
39 more people are available in the full profile.
Complete people profiles for PacBio
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of PacBio
PacBio is a publicly listed company on the NASDAQ with ticker symbol PACB in USA, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date05 Nov 2010
- Listed onFRA: P09
- Listed entityPacific Biosciences of California, Inc.
- Exchange sectorHealth technology
- ISINUS69404D1081
- Share price$2.05 (-2.38% on the day) · 2026-10-13
- Market capitalisation$637.2M
- EPS (diluted, trailing year)$-0.43
- Volume (last session)12,286,886
Financials of PacBio
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $160.0M | -$546.4M | -$165.3M |
| 2024 | $154.0M | -$309.9M | -$212.1M |
| 2023 | $200.5M | -$306.7M | -$277.7M |
| 2022 | $128.3M | -$314.2M | -$287.5M |
| 2021 | $130.5M | -$181.2M | -$166.6M |
Detailed financial statements for PacBio
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by PacBio
PacBio has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Circulomics and Omniome.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Platforms for genome profiling and biomarker analysis are developed. | circulomics.com | Baltimore, United States | 2009 | Aug 2021 | •••• | |
Genome sequencing platform is provided for clinical diagnostics. | omniome.com | San Diego, United States | 2013 | Jul 2021 | •••• |
Complete acquisition details for PacBio
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of PacBio
6 dated milestones of PacBio across 17 years, from founding to its latest funding, stage changes and deals.
- Founded PacBio is founded.
- Funding First funding round of $50.0M.
- IPO Lists on the stock exchange (IPO).
- Funding Latest funding round, Post-IPO, of $900.0M.
- Acquisition Acquires Omniome.
- Acquisition Acquires Circulomics.
Competitors of PacBio
PacBio has 3 listed competitors in our database, 3 of them funded. They include Omniome, Complete Genomics and Bionano.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omniome.com | 2013 | San Diego, United States | $160.23M | 164 | Genome sequencing platform is provided for clinical diagnostics. | |
| completegenomics.com | 2006 | San Jose, United States | $124.99M | 70 | DNA sequencing platform for human genome analysis is developed. | |
| bionano.com | 2002 | San Diego, United States | $124.2M | Provider of genome analysis solutions to researchers and clinicians |
Detailed competitors of PacBio
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of PacBio
The website of PacBio (pacb.com) receives about 116.5K visits a month.
- Monthly visits116.5K
▼ 1.3% vs previous month
Websites whose visitors overlap most with PacBio. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| illumina.com | 100% | 672.7K | #61,793 | View details | |
| completegenomics.com | 82% | 11.4K | #2,001,051 | View details | |
| biorxiv.org | 80% | 3M | #19,954 | View details | |
| appliedbiosystems.com | 77% | View details | |||
| cell.com | 77% | 5M | #14,619 | View details | |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
| •••••••••• | ••••••.com | ••% | •.•M | #••••• | – |
All 40 similar websites and full traffic analytics for PacBio
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 40 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Genomics & Gene Therapy Platforms
3 companies that operate in the same segment as PacBio (Genomics & Gene Therapy Platforms) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
mRNA-based therapeutics for diseases including cancer and infections are developed. | 2010 | Cambridge, Massachusetts, United States | USD 2.78 B | USD 1.94 B | 5,800 | |
Digital sequencing technology for cancer detection is developed. | 2012 | Redwood City, California, United States | USD 557.5 M | USD 982.02 M | 4,867 | |
Circulating tumor DNA is screened for early cancer detection. | 2016 | Menlo Park, California, United States | USD 2 B | USD 147.17 M | 1,141 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Pacbio
Complete news archive for PacBio
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about PacBio
PacBio was founded in 2004 and raised its 1st funding round 3 years after it was founded.
PacBio is headquartered in Menlo Park, United States. It is registered at Menlo Park, California, United States.
Christian Henry is the CEO of PacBio, as recorded in our data.
PacBio is a funded company, having raised a total of $395M across 11 funding rounds to date. The company's 1st funding round was a Grant of $2.88M, raised on Jan 2007.
PacBio has 575 employees.
Annual revenue of PacBio is $160M as on Dec 31, 2025.
PacBio was founded in 2004 in Menlo Park, United States, within the biotechnology sector. Instrument systems and associated software for real-time sequencing of single molecules are developed by the company. A sequencing platform based on two proprietary technologies is utilized to enable this process. Analytical software for refining sequence data processing and generating reports is also provided, supporting operations in genomic research across the United States.
PacBio's top competitors include Complete Genomics, Omniome and Bionano.
Yes, PacBio is publicly traded on NASDAQ under the ticker symbol PACB.
PacBio has made 2 acquisitions, including Circulomics, and Omniome.
PacBio has 21 investors. Key investors include Morgan Stanley, Kleiner Perkins, SoftBank Group, Blackstone, and AllianceBernstein.
PacBio operates through Pacific Biosciences Of California, Inc..